Changsha Listed Among China’s Top 20 Cities in Biomedical Industry
The Hs Academy and the Chinese Society of Biotechnology announced the China Biomedical Industry Barometer (CBIB) at the China Bioindustry Convention on June 10. The first batch of constituent institutions were also announced, including the lists of 20 constituent cities, 20 constituent parks, 60 constituent enterprises (30 pharmaceutical companies, 20 medical equipment companies, and 10 service companies), and 20 investment institutions.
Changsha was on the list of the 20 constituent cities. Changsha’s two industrial parks -- the Changsha High-tech Industrial Development Zone and Liuyang Economic and Technological Development Zone were included in the list of 20 constituent parks. At present, there are more than 170 biomedical manufacturing enterprises in the city, including 66 enterprises above a designated size. There were 1,500 drug varieties produced.
Several pharmaceutical industrial clusters have been initially formed in Changsha, including Biomedical Industrial Cluster in Liuyang Economic and Technological Development Zone; Haiping Medical Equipment Park and Pharmaceutical Production Logistics Base in Changsha High-tech Industrial Development Zone; Tongguan Chemical Raw Medicine Production Base in Wangcheng Economic and Technological Development Zone; and, Pharmaceutical Logistics Base in Jinxia Economic and Technological Development Zone.
As more and more new key projects are based in Changsha and many intelligent manufacturing projects have been transformed and upgraded, the agglomeration effect has become more significant.
Translator: Kuang Zhenzhen
Chinese source: icswb.com